Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BISKEN APOTEKDRIFT AS
AS
Active
Org 830754172
Søndre Øyjorden 75, 5038 Bergen
Retail sale of pharmaceutical products · NACE 4773
Est. 2023
5 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 10,3M
+182% vs 2023
EBITDA margin
0.3%
+121% vs 2023
Equity ratio
-18.2%
Financial strength
Net profit 2024
NOK -284K
+10% vs 2023
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 10,3M
+182%
EBITDA
NOK 27K
+121%
Net profit
NOK -284K
+10%
Total assets
NOK 3,1M
-36%
Equity
NOK -568K
-100%
Employees
5
—
Company information
Legal name
BISKEN APOTEKDRIFT AS
Org number
830754172
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
1. februar 2023
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder alene.
Company purpose
Apotekdrift.
Contact
Address
Søndre Øyjorden 75, 5038 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Bergen
All Norway companies
Revenue
NOK millions
0M
3M
6M
9M
12M
4M
2023
10M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
3 658
10 334
Staff expenses
−861
−2 179
EBITDA
−129
27
Depreciation & amort.
−90
−148
EBIT
−219
−122
Net financials
−96
−162
Profit before tax
−314
−284
Tax
−0
−0
Net profit
−314
−284
Balance sheet
NOK thousands
Item
2023
2024
Total assets
4 917
3 125
Equity
−284
−568
Long-term debt
946
786
Short-term debt
4 255
2 908
Total debt
5 201
3 694
Financial ratios
5-year trend
EBITDA margin
0.3%
This company
15.8%
Market median
-98% vs market
2023
2024
Equity ratio
-18.2%
This company
38.2%
Market median
-148% vs market
2023
2024
Return on equity
-28388800.0%
This company
18.4%
Market median
-154287057% vs market
2023
2024
Net profit margin
-2.7%
This company
8.1%
Market median
-133% vs market
2023
2024
Asset turnover
3.31×
This company
1.12×
Market median
+196% vs market
2023
2024
Debt / equity
6.50×
This company
0.62×
Market median
-948% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-06 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
TJ
Tore Jakob Meltevik
Chief Executive Officer
Chief Executive Officer
2023
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Tjm Holding As
Company
100.0%
100.0%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Tjm Holding As
BISKEN APOTEKDRIFT AS
(this company)
Board network connections
Board members of BISKEN APOTEKDRIFT AS also hold positions in
0
other companies.
Person
Role here
Other companies
Tore Jakob Meltevik
Chief Executive Officer
0 companies